On November 12th, PW MEDTECH (01358) spent 1.034 million Hong Kong dollars to repurchase 1 million shares.
PwC Holdings Limited (01358) announced on November 12, 2024 that it will spend HK$103.4 million to repurchase its shares.
PW MEDTECH (01358) announced that on November 12, 2024, it will spend 1.034 million Hong Kong dollars to repurchase 1 million shares at a repurchase price of 1.03-1.04 Hong Kong dollars per share.
Related Articles
Shenzhen Zhongjin Lingnan Nonfemet (000060.SZ) acquires the minority shareholder equity in its holding subsidiary.
Guangdong Zhongsheng Pharmaceutical (002317.SZ): The first participant has been enrolled in the phase III clinical trial of the innovative drug Angla Diweiyekeli.
Shenzhen Kstar Science & Technology director Li Chunying plans to reduce his holdings by no more than 424,000 shares.
Shenzhen Zhongjin Lingnan Nonfemet (000060.SZ) acquires the minority shareholder equity in its holding subsidiary.
Guangdong Zhongsheng Pharmaceutical (002317.SZ): The first participant has been enrolled in the phase III clinical trial of the innovative drug Angla Diweiyekeli.
Shenzhen Kstar Science & Technology director Li Chunying plans to reduce his holdings by no more than 424,000 shares.
